Alibaba’s Hong Kong-listed shares rose 2.1% to HK$113.10 on Tuesday after reports surfaced that the company plans to integrate food delivery platform Eleme and travel service Fliggy into its core e-commerce operations. The move is seen as a strategic restructuring aimed at creating a more comprehensive consumer platform amid intensifying competition in China’s digital economy.
Citi analysts responded positively to the news, maintaining a “Buy” rating on Alibaba (NYSE:BABA) with a price target of HK$165. They noted the integration could lead to greater capital investment and resource allocation for Alibaba’s food and travel verticals, potentially accelerating its expansion beyond traditional e-commerce.
The restructuring aligns with a broader push among China’s internet giants to capture a larger share of the consumer services market. Rival JD.com (HK:9618) recently launched a travel platform, entering a space already dominated by firms like Trip.com Group Ltd (HK:9961) and Meituan (HK:3690).
The timing of Alibaba’s strategy also benefits from improving retail sentiment in China. Citi highlighted that recent government stimulus measures and consumption incentives have supported a rebound in consumer spending. Alibaba’s strong performance during the recent 6.18 shopping festival reflected this trend, further validating its platform consolidation strategy.
Investors appear to welcome the shift, with the Hang Seng Index gaining nearly 2% alongside Alibaba’s rally. As the tech giant streamlines operations and deepens its presence across consumer segments, analysts believe it is well-positioned to drive long-term growth in an increasingly competitive landscape.


TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Apple Turns 50: From Garage Startup to AI Crossroads
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire 



